US Broker Ratings

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Potential Upside and Analyst Ratings

Healthcare Services Group, Inc. (NASDAQ: HCSG) has been gaining attention in the healthcare sector, particularly in the medical care facilities industry. Based in Bensalem, Pennsylvania, the..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 51% Potential Upside

Pulse Biosciences, Inc. (NASDAQ: PLSE), a pioneering company in the healthcare sector, is drawing attention from investors with its cutting-edge innovations in bioelectric medicine. Specializing in..

MannKind Corporation (MNKD) Stock Analysis: 66.57% Potential Upside Captivates Investors

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology sector, offers a compelling opportunity for investors, bolstered by a promising 66.57% potential upside based on..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Promising 20% Upside in Biotech Innovation

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is currently capturing the attention of investors with its promising pipeline of peptide therapeutics aimed at addressing complex hematology and blood..

LivaNova PLC (LIVN) Stock Analysis: Exploring a 17% Potential Upside in the Medical Device Sector

LivaNova PLC (NASDAQ: LIVN), a leading player in the medical technology space, is currently garnering significant attention from investors with its promising 17% potential upside. Headquartered..

Phreesia, Inc. (PHR) Investor Outlook: A 70% Potential Upside in the Healthcare SaaS Space

Phreesia, Inc. (NYSE: PHR) is making waves in the health information services sector with its innovative SaaS-based solutions designed to streamline patient and healthcare provider interactions...

BioCryst Pharmaceuticals (BCRX) Stock Analysis: A Rare Disease Innovator with 189% Upside Potential

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is making waves in the biotechnology sector, primarily due to its focus on developing treatments for rare diseases. With a market..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A High-Stakes Bet with 358% Potential Upside

For investors seeking high-growth opportunities in the biotechnology sector, Janux Therapeutics, Inc. (NASDAQ: JANX) presents an intriguing proposition. A clinical-stage biopharmaceutical company, Janux is at the..

Certara, Inc. (CERT) Stock Analysis: A Healthcare Innovator with 31.79% Potential Upside

Certara, Inc. (CERT) is making waves in the healthcare sector with its innovative approach to biosimulation and model-informed drug development. Based in Radnor, Pennsylvania, Certara provides..

Astrana Health Inc. (ASTH) Stock Analysis: Significant Revenue Growth and a Promising 26% Upside

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the healthcare sector, is making waves with its robust revenue growth and substantial potential upside. With a..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 25.71% Upside Potential in the Healthcare Sector

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) is capturing investor attention in the healthcare arena, particularly within the Medical Instruments & Supplies industry. With a market cap..

Harrow, Inc. (HROW) Stock Analysis: A 47.63% Potential Upside in the Healthcare Sector

Harrow, Inc. (HROW), a distinguished player in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing, has been capturing investor attention with..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Evaluating Its 18.67% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, specifically within the medical care facilities industry, has been drawing attention due to..

PACS Group, Inc. (PACS) Stock Analysis: Healthcare Player with a 6.48% Upside and Strong Buy Ratings

PACS Group, Inc. (PACS), a prominent player in the healthcare sector, specifically in the medical care facilities industry, has captured the attention of investors with its..

MiMedx Group, Inc (MDXG) Stock Analysis: A Biotech Gem with 96.67% Upside Potential

MiMedx Group, Inc. (NASDAQ: MDXG) stands out in the biotechnology sector, not just for its innovative approach to healthcare but also for its appealing investment potential...

10x Genomics, Inc. (TXG) Stock Analysis: A Closer Look at Valuation Challenges Amidst Sector Potential

For investors navigating the dynamic landscape of health information services, 10x Genomics, Inc. (NASDAQ: TXG) presents a compelling case study. With its innovative platforms designed to..

Viridian Therapeutics, Inc. (VRDN): Growth Potential in Biotechnology with an 81,958% Revenue Surge

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a promising player in the biotechnology sector, is capturing the attention of investors with its impressive revenue growth and a robust..

Beam Therapeutics Inc. (BEAM): An Investor’s Insight into Its 34% Upside Potential and Strategic Collaborations

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneer in precision genetic medicines, is capturing the attention of investors with its innovative approach to treating serious diseases. Based..

LeMaitre Vascular (LMAT) Stock Analysis: Exploring a 23.66% Upside in the Healthcare Sector

For investors eyeing opportunities within the healthcare sector, LeMaitre Vascular, Inc. (NASDAQ: LMAT) presents a compelling case. Headquartered in Burlington, Massachusetts, LeMaitre specializes in medical instruments..

Amphastar Pharmaceuticals, Inc. (AMPH): Investor Outlook with a 7.39% Upside Potential

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector, focuses on the development and commercialization of generic and proprietary pharmaceuticals. Headquartered in Rancho..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds